IBER.WS
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
IBER.WS
Delisted
IBER.WS was delisted on the 15th of February, 2023.
33 hedge funds and large institutions have $1.78M invested in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.
Holders
33
Holders Change
-5
Holders Change %
-13.16%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
2
Closed
5
Calls
$2.29M
Puts
–
Net Calls
+$2.29M
Net Calls Change
-$7K
Top Buyers
1 |
ETH
1
Exos TFP Holdings
New York
|
$1.26K |
2 |
CS
2
Clear Street
New York
|
$4K |
3 |
EFI
3
EHP Funds Inc
Toronto,
Canada
|
$1K |